How Creatine Powers the Muscle-Brain Axis via BDNF

When most people think about creatine supplementation, they picture ATP regeneration in muscle cells and faster post-workout recovery. That story is accurate — but incomplete. A growing body of peer-reviewed research suggests that creatine's most mechanistically interesting effects may operate along a pathway that most supplement labels never mention: the muscle-brain axis, a bidirectional signaling network that links skeletal muscle activity to neurological health and cognitive performance.

A landmark 2025 review published in Frontiers in Nutrition introduced a formal framework for understanding creatine as a modulator of this axis — not merely an energy buffer, but a molecule capable of influencing the myokine-mediated crosstalk between contracting muscle and the brain. Here's what the research actually shows, and why it matters for anyone supplementing creatine for performance or cognitive benefit.

What Is the Muscle-Brain Axis?

The muscle-brain axis refers to the bidirectional chemical signaling between skeletal muscle and the central nervous system. When muscle tissue contracts — during resistance training, aerobic exercise, or everyday movement — it secretes a class of signaling proteins called myokines. These molecules act similarly to hormones, circulating through the bloodstream to exert systemic effects on multiple organ systems, including the brain.

The most studied myokines in the context of brain health include:

• Brain-derived neurotrophic factor (BDNF) — supports neuron survival, synaptic plasticity, and hippocampal neurogenesis
• Irisin — derived from the FNDC5 protein, crosses the blood-brain barrier and promotes hippocampal plasticity
• Interleukin-6 (IL-6) — acts as an anti-inflammatory myokine during moderate exercise, with neuroprotective downstream effects
• Insulin-like growth factor-1 (IGF-1) — promotes neuronal survival and myelination
• Cathepsin B — a lysosomal protease released during running, linked to memory function in preclinical models

Together, these molecules form a biochemical pipeline connecting the health of your skeletal muscle to the health of your brain. The more vigorously — and sustainably — your muscles can work, the richer the myokine signal your brain receives.

Where Creatine Enters the Equation

Creatine is best known for its role in the phosphocreatine system: the rapid regeneration of ATP during high-intensity effort. But the 2025 Frontiers in Nutrition review proposes a more expansive mechanism with four interconnected components:

1. Enhanced ATP availability in muscle — more sustained, higher-quality contractions translate to greater myokine secretion per training session
2. Reduced oxidative stress and inflammation — creatine creates a more favorable physiological environment for myokine release and receptor signaling downstream
3. Direct brain uptake — supplemental creatine crosses the blood-brain barrier to a modest but meaningful degree, restoring brain phosphocreatine stores, especially in individuals with low baseline levels
4. Improved glucose metabolism — better cellular energy homeostasis in both muscle and neural tissue reduces the metabolic disruption that impairs signaling fidelity

This multi-pathway profile distinguishes creatine from most ergogenic compounds, which operate through a single mechanism. Creatine engages both the peripheral (muscular) and central (neural) arms of the muscle-brain axis simultaneously — a pleiotropic profile that makes it uniquely positioned at the intersection of physical and cognitive supplementation.

BDNF: The Critical Neurochemical Bridge

Of all the myokines implicated in muscle-brain communication, BDNF has attracted the most intensive scientific scrutiny — and for good reason. BDNF supports the differentiation, maturation, and survival of neurons in the central nervous system and plays a central role in synaptic plasticity, hippocampal neurogenesis, and learning-related cognitive processes. Low BDNF levels have been associated with cognitive decline, depression, and increased neurodegenerative disease risk.

The creatine connection is mechanistically elegant: exercise-induced BDNF release is partly coupled to the intensity and duration of muscular effort. When phosphocreatine stores are adequately replenished through supplementation, athletes and exercisers can sustain higher-quality contractions for longer before energy failure sets in — potentially amplifying the BDNF signal the muscles send to the brain.

A 2024 systematic review and meta-analysis examining the effects of creatine supplementation on cognitive function in adults found significant improvements in working memory, processing speed, and fluid intelligence across 14 randomized controlled trials. The authors noted that the observed cognitive benefits likely involve both direct brain energy support and indirect effects mediated through enhanced exercise capacity — a finding entirely consistent with the BDNF pathway hypothesis.

The Supporting Cast: Irisin, IL-6, and IGF-1

While BDNF commands the most attention, the muscle-brain axis is an ensemble performance. Irisin — released during physical activity from the FNDC5 precursor protein — has demonstrated the ability to cross the blood-brain barrier in preclinical models and induce hippocampal plasticity, enhance memory consolidation, and reduce markers of neuroinflammation. Its release is tightly coupled to exercise intensity, reinforcing the theoretical mechanism by which creatine's capacity to extend high-quality muscular output could upstream-enhance these neuroprotective signals.

Interleukin-6, long categorized as a pro-inflammatory cytokine in the context of chronic disease, functions as a potent anti-inflammatory myokine in the acute exercise setting. The transient IL-6 spike during sustained muscular effort has been linked to improved fat oxidation, better glucose uptake, and downstream anti-inflammatory signaling — all relevant to the metabolic conditions that support long-term brain health.

IGF-1 rounds out the central cast with well-established neuroprotective effects: it promotes neuronal survival, axonal myelination, and synaptic density. The convergence of these signals during and after adequately fueled exercise creates a systemic biochemical environment that is profoundly favorable for cognitive health — and creatine operates as an upstream amplifier of that entire cascade.

What the Clinical Evidence Shows

Translating mechanistic hypotheses into human clinical outcomes is where the story gets appropriately nuanced. A 2026 review in the Journal of Nutritional Physiology evaluated the current state of evidence on creatine and brain health, concluding that creatine holds genuine translational value for cognitive support while flagging the need for larger, longer trials with standardized brain creatine quantification methods.

Specific population subgroups appear to show the most robust responses:

• Older adults: A 2025 Frontiers in Nutrition review on creatine, aging, and the muscle-brain axis found that age-related declines in creatine synthesis and creatine transporter expression make older adults disproportionately responsive to supplementation — for both muscle preservation and myokine-mediated cognitive outcomes.
• Vegetarians and vegans: Individuals who consume no dietary creatine (found primarily in meat and fish) have substantially lower baseline tissue saturation, making them the highest responders to supplementation across both physical and cognitive outcome measures.
• Athletes in heavy training blocks: Higher training volumes generate greater myokine signals — and creatine ensures those signals aren't cut short by energy failure in the muscle. The muscle-brain axis may be most impactful precisely when training stress is highest.

Practical Implications: Dose, Form, and Consistency

Virtually every study demonstrating significant cognitive and muscle-brain axis effects uses a daily dose of 3–5 grams of creatine monohydrate — the form with the most extensive safety and efficacy data by a wide margin. Key practical considerations for those prioritizing the neurological arm of creatine's effects:

• Consistency over timing: Unlike pre-workout stimulants, creatine's cognitive benefits require sustained elevation of brain and muscle phosphocreatine stores. Daily dosing — regardless of whether you're training that day — is the protocol the research supports.
• Full clinical dose: Sub-threshold doses of 1–2g do not reliably reproduce the cognitive findings in the literature. The 5g dose used in the 2025 muscle-brain axis review reflects the threshold at which tissue saturation reaches clinically meaningful levels.
• Zero added sugar: Sugar-laden delivery vehicles introduce glycemic variability that can counteract the stable metabolic environment creatine's brain energy benefits depend on. If cognitive performance is the goal, the delivery format matters.
• Long-term commitment: The myokine amplification pathway operates on a training-adaptation timescale. Creatine's role in that system compounds over weeks and months of consistent use — not a single pre-workout dose.

The emerging picture from exercise physiology, nutritional neuroscience, and clinical trial data is increasingly coherent: creatine is not a muscle supplement with incidental brain effects. It is a pleiotropic modulator of the biochemical axis that links physical performance to cognitive health — and the full scientific story is only beginning to be told.